The effect of intracameral anesthesia on macular thickness and ganglion cell-inner plexiform layer thickness after uneventful phacoemulsification surgery

ISRCTN ISRCTN94155463
DOI https://doi.org/10.1186/ISRCTN94155463
Secondary identifying numbers Balikesir University, 2013-16
Submission date
01/09/2013
Registration date
20/09/2013
Last edited
26/08/2014
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Eye Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
Pseudophakic cystoid macular edema (CME) remains as one of the most common causes of unfavourable visual outcomes after uneventful cataract surgery. Its incidence has been reported as 0.1 to 5% in healthy population. The exact reason is not fully understood. An ideal anaesthetic (numbing) agent for cataract surgery should facilitate this stressful procedure for both the surgeons and the patient. The use of topical anaesthetic agents has gained widespread acceptance, with a preference rate of about 61% among all eye surgeons. Many surgeons who perform cataract surgery under topical anaesthesia also prefer the use of supplementary intracameral lidocaine (used for pupil dilation) during the surgery. Although a conclusion about its safety has not been reached yet, the toxic effects of lidocaine on retinal ganglion cells have been confirmed by previous animal and human studies. In this study we find out the effects of intracameral anaesthesia on specific properties of the macular cells of the eye, after an uneventful cataract surgery in otherwise healthy subjects.

Who can participate?
Patients, aged between 45 and 85 years, requiring cataract surgery for the treatment of senile cataract were enrolled.

What does the study involve?
All patients were randomly assigned to one of two groups : the intracameral lidocaine group received an intracameral injection (into the eye) of lidocaine at the beginning of the procedure, while the sham injection group received an intracameral injection of a dummy. In both groups, two surgeons performed a standard cataract surgery.

What are the possible benefits and risks of participating?
Patients are treated with cataract surgery for the regaining their vision. Some complications can occur such as infection, tear and poor vision after surgery. However, the tests done in this study do not have any potential risks such as radiation exposure.

Where is the study run from?
The study ran from the ophthalmology department of Balikesir University, Turkey.

When is study starting and how long is it expected to run for?
The study ran between March 2013 and June 2013.

Who is funding the study?
The study was funded by the ophthalmology department, Balikesir University, Turkey.

Who is the main contact?
Dr Esin Sogutlu Sarý
+90 505 641 0199
dresinsogutlu@gmail.com

Contact information

Dr Esin Sogutlu Sarý
Scientific

Paþaalaný mah. 253. sok Deniz 2 apt daire:4
Balýkesir
Balýkesir
10123
Türkiye

Phone +90 505 641 0199
Email dresinsogutlu@gmail.com

Study information

Study designRandomized and double masked study
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeDiagnostic
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleThe effect of intracameral anesthesia on macular thickness and ganglion cell-inner plexiform layer thickness after uneventful phacoemulsification surgery: Prospective and randomized controlled trial.
Study objectivesTo evaluate the effect of intracameral lidocaine anesthesia on macular thickness and macular ganglion cell-inner plexiform layer (GC-IPL) thickness following uneventful phacoemusification in healthy subjects.
Ethics approval(s)Balikesir University Ethical Committee approved before inclusion of the first cataract patients
Health condition(s) or problem(s) studiedSenile cataract
InterventionOptical coherence tomography imaging was performed before and after the cataract surgery
All patients were randomly assigned a number based on a surgical chart:
1. intracameral lidocaine group received an intracameral injection of preservative-free lidocaine 1% (0.5 cc) at the beginning of the procedure
2. sham injection group received intracameral injection of balanced salt solution (BSS) (0.5 cc)
All patients underwent standard phacoemulsification surgery. Optical coherence tomography imaging was performed before surgery and at 1 day, 2 day, 1 week, 1 month and 3 months after surgery.
Intervention typeOther
Primary outcome measureMacular thickness analyses with spectral domain optical coherence tomography measured at baseline and at 1 day, 2 days, 1 week, 1 month and 3 months after surgery.
Secondary outcome measuresGanglion cell-inner plexiform layer and peripapiller retinal nerve fiber layer thickness analyses as well as visual acuity changes measured at baseline and at 1 day, 2 days, 1 week, 1 month and 3 months after surgery.
Overall study start date01/03/2013
Completion date01/06/2013

Eligibility

Participant type(s)Patient
Age groupSenior
SexBoth
Target number of participants100
Key inclusion criteriaPatients requiring phacoemulsification surgery for the treatment of senile cataract were included. Inclusion criteria were the presence of senile cataract between 45 and 85 years of age and a clear fundus examination before the surgery.
Key exclusion criteriaExclusion criteria were
1. Pre-existing macular diseases such as macular edema, epiretinal membrane, macular hole and age-related macular degeneration
2. Ocular diseases such as diabetic retinopathy, glaucoma and previous uveitis
3. Pre-existing refractive error: ±3.00 dioptries
4. History of previous intraocular surgery (except cataract surgery in the fellow eye within the previous 6 months) or laser treatment
5. Diabetes, hypertension or other systemic disease that could affect the eye and topical and/or systemic medications with known interference on macular thickness such as steroids and diuretics.
6. Patients with operative complications and eyes with media opacities which could reduce the signal strength and lead to a segmentation error in preoperative measurements were also excluded from the study.
Date of first enrolment01/03/2013
Date of final enrolment01/06/2013

Locations

Countries of recruitment

  • Türkiye

Study participating centre

Paþaalaný mah. 253. sok Deniz 2 apt daire:4
Balýkesir
10123
Türkiye

Sponsor information

Balikesir University (Turkey)
University/education

Ophthalmology Department
Bigadic Road
17th km, Cagis Campus
Balikesir
n/a
Türkiye

Email dresinsogutlu@gmail.com
ROR logo "ROR" https://ror.org/02tv7db43

Funders

Funder type

University/education

Ophthalmology Department, Balikesir University, Turkey

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/03/2014 Yes No